|1.||Dekker, Robert F H: 3 articles (01/2015 - 03/2008)|
|2.||Barbosa, Aneli M: 3 articles (01/2015 - 03/2008)|
|3.||Fonseca, Eveline A I: 2 articles (09/2011 - 03/2008)|
|4.||Cólus, Ilce Mara de Syllos: 1 article (01/2015)|
|5.||Figueiredo, Suely Gomes de: 1 article (01/2015)|
|6.||Oliveira, Marcelo Tempesta de: 1 article (01/2015)|
|7.||Antunes, Lusânia Maria Greggi: 1 article (01/2015)|
|8.||Souza, Marilesia Ferreira de: 1 article (01/2015)|
|9.||Malini, Maressa: 1 article (01/2015)|
|10.||Castro, Inar A: 1 article (09/2011)|
09/01/2011 - "These results demonstrate that botryosphaeran has protective effects by reducing the symptoms of cachexia in Diabetes mellitus. "
09/01/2011 - "Based on these findings, we conclude that botryosphaeran possesses hypoglycemic and hypocholesterolemic properties in conditions of diabetes mellitus and hyperlipidemia, respectively, and may be used as an oral anti-diabetic agent."
01/01/2015 - "In the present study, the modulation of gene expression via RT-qPCR and cell cycle kinetics via flow cytometry were assessed in human normal and tumor (Jurkat) lymphocytes after treatment with botryosphaeran (a fungal (1→3)(1→6)-β-d-glucan) from Botryosphaeria rhodina MAMB-05. "
01/01/2015 - "The repression of the CCR5 gene following botryosphaeran treatment, either alone or in combination with DXR, in tumor lymphocytes indicates a possible affinity of this particular (1→3)(1→6)-β-d-glucan for the receptor CCR5. "
|4.||Body Weight (Weight, Body)
03/01/2008 - "Variance analysis (ANOVA) showed no significant differences (p<0.05) among the median body weights of the groups of mice treated with botryosphaeran during experiments evaluating genotoxic and protective activities of botryosphaeran. "
09/01/2011 - "The plasma glucose level was reduced by 52% in the diabetic group of rats after administration of 12 mg botryosphaeran/kg body weight of the rats (b.w.)/day by gavage over 15 days. "
|1.||CCR5 Receptors (CCR5 Receptor)